Liquid Biopsy Oncology Market

This report provides an overview and in-depth market analysis of liquid biopsy clinical and research products used in oncology. For this report, market size and growth forecasts are segmented by type of clinical/research application and geographic region. Types of biomarkers used in liquid biopsy assays/tests include circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles/exosomes, and other biomarkers. While these technologies and products are reviewed in detail, this report does not attempt to segment product and service market size by biomarker; the liquid biopsy market is increasingly complex, growing rapidly, and currently geared towards ctDNA, making any segmentation of biomarker by market value very difficult and prone to large errors. 

This report provides the following information: 

•  an epidemiological overview of the most common types of cancer 

• product analysis by biomarker segment and application 

• competitive analysis of industry leaders and emerging competitors 

• insight into factors driving and limiting market growth 

• market size and five-year forecasts (2025-2030) by application and geographic region